NCT03193372View on ClinicalTrials.gov

A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea

CompletedOBSERVATIONAL

Enrollment

2,200

Participants

Timeline

Start Date

July 20, 2017

Primary Completion Date

August 8, 2017

Study Completion Date

November 15, 2017

Conditions

Rosacea

Interventions

DRUG

Azelaic Acid (Finacea Foam, BAY39-6251)

Finacea Foam, Active substance Azelaic acid

Trial Locations (1)

34685

Xcenda, LLC, Palm Harbor

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Bayer

INDUSTRY

lead

LEO Pharma

INDUSTRY